Bone mineral density changes following discontinuation of ronacaleret treatment: off-treatment extension of a randomized, dose-finding phase II trial.

Saved in:
Bibliographic Details
Title: Bone mineral density changes following discontinuation of ronacaleret treatment: off-treatment extension of a randomized, dose-finding phase II trial.
Authors: Fitzpatrick LA; GlaxoSmithKline, King of Prussia, PA 19406, USA. Electronic address: lorraine.a.fitzpatrick@gsk.com., Wooddell M; GlaxoSmithKline, King of Prussia, PA 19406, USA., Dabrowski CE; GlaxoSmithKline, King of Prussia, PA 19406, USA., Cicconetti G; GlaxoSmithKline, King of Prussia, PA 19406, USA., Gordon DN; GlaxoSmithKline, King of Prussia, PA 19406, USA.
Source: Bone [Bone] 2014 Oct; Vol. 67, pp. 104-8. Date of Electronic Publication: 2014 May 02.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2763
DOI:10.1016/j.bone.2014.04.024